Advisory on the use of ivermectin for unproven clinical uses

This article has been migrated from an earlier version of the site and may display formatting inconsistencies.

The Health Sciences Authority (HSA) advises members of the public not to purchase, import or use ivermectin for the prevention or treatment of conditions for which it has not been proven to be safe and effective. These include the prevention or treatment of viral infections such as COVID-19 and Zika virus infection, immune-related conditions such as lupus and rheumatoid arthritis, as well as various cancers and other conditions for which there is no established evidence of benefit.

Ivermectin is a prescription-only medicine in Singapore. Doctors may prescribe oral ivermectin for the treatment of parasitic worm infections, while its topical formulation is used for the treatment of a skin condition known as rosacea. It has not been proven effective for any other use. There is no robust scientific evidence from well-conducted clinical trials to support its use for viral infections, immune-related conditions, or cancers.

Self-medicating with ivermectin can be dangerous. It may lead individuals to wrongly believe that ivermectin can protect them or treat their condition. This may delay proper medical diagnosis and treatment, and expose them to unnecessary harm. Ivermectin may also interact with other medications, including blood-thinners, which may increase the risk of bleeding.

Side effects associated with ivermectin include vomiting, diarrhoea, stomach pain, neurologic adverse events (dizziness, seizures, confusion), a sudden drop in blood pressure, severe skin rash that may require hospitalisation, and liver injury (hepatitis).

Do not purchase ivermectin from online platforms, overseas websites or other unauthorised sources, as such products may be illegal, counterfeit, substandard or unsafe.

Consult a doctor for proper diagnosis of your condition, appropriate treatment and medical advice.